Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies

Since 2008, the direct-acting oral anticoagulants (DOACs) have expanded the therapeutic options of cardiovascular diseases with recognized clinical and epidemiological impact, such as non-valvular atrial fibrillation (NVAF) and venous thromboembolism (VTE), and also in the preventive setting of orth...

Descripción completa

Detalles Bibliográficos
Autores principales: Raschi, Emanuel, Bianchin, Matteo, Ageno, Walter, De Ponti, Roberto, De Ponti, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107188/
https://www.ncbi.nlm.nih.gov/pubmed/27696300
http://dx.doi.org/10.1007/s40264-016-0464-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107188/
https://www.ncbi.nlm.nih.gov/pubmed/27696300
http://dx.doi.org/10.1007/s40264-016-0464-3

Ejemplares similares